Sequential Mycoplasma pneumoniae pneumonia and Chromobacterium violaceum skin abscess in a pediatric patient

Weizhen Guo1, Iris Wai Sum Li2, Xi Li3

  • 1The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China. gzgwz@126.com.

Insights

This report details the first case of Chromobacterium violaceum infection in a child following Mycoplasma pneumoniae pneumonia. The rare bacterial super-infection presented as a skin abscess, successfully treated with antibiotics and drainage.

Area of Science:

  • Pediatric Infectious Diseases
  • Microbiology
  • Clinical Case Reports

Background:

  • Mycoplasma pneumoniae is a frequent cause of pediatric community-acquired pneumonia.
  • Bacterial super-infections are uncommon, typically limited to Streptococcus pneumoniae and Haemophilus influenzae.
  • Chromobacterium violaceum is a rare pathogen in pediatric super-infections.

Purpose of the Study:

  • To report the first documented case of Chromobacterium violaceum super-infection after Mycoplasma pneumoniae pneumonia in a child.
  • To highlight the unusual presentation and successful management of this rare co-infection.

Main Methods:

  • Case report of a 12-month-old girl.
  • Clinical observation of symptoms including fever and a progressing hand abscess.
  • Microbiological identification of Chromobacterium violaceum.
  • Treatment with intravenous meropenem and surgical abscess drainage.

Main Results:

  • The patient presented with fever and a skin abscess on the index finger.
  • Chromobacterium violaceum was identified as the causative agent of the super-infection.
  • Successful recovery following antibiotic therapy and surgical intervention.

Conclusions:

  • Mycoplasma pneumoniae pneumonia can precede rare bacterial super-infections like Chromobacterium violaceum.
  • This case underscores the importance of considering unusual pathogens in pediatric respiratory infections with secondary manifestations.
  • Prompt diagnosis and appropriate treatment are crucial for favorable outcomes in such cases.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
797
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
2.8K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
784
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.5K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
816
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214